1. Introduction {#s0010}
===============

Many pathogens, including bacteria, viruses and parasites, are known to cause gastrointestinal infections in humans and animals. Diarrhoea caused by these pathogens is one of the principal reasons for high morbidity in humans in developed and developing countries, often resulting in mortality in underprivileged communities ([@bib115]). Among parasitic pathogens, *Cryptosporidium* and *Giardia* are frequently associated with diarrhoea and pose a considerable threat to human and animal health globally ([@bib168], [@bib375]).

*Cryptosporidium* and *Giardia* can be transmitted via the faecal--oral route, following direct or indirect contact with infected hosts ([@bib58]). Members of these genera have been responsible for community-wide outbreaks associated with drinking or recreational water ([@bib315]). Although infections are often self-limiting in immunocompetent individuals ([@bib67], [@bib111]), they can become severe and chronic in infants, elderly people and immunocompromised or -suppressed individuals ([@bib159], [@bib289]). Investigations of outbreaks and case--control studies have shown clearly that cryptosporidiosis and giardiasis can be transmitted from humans to humans (anthroponotic) or from animals to humans (zoonotic) ([@bib408]). Therefore, identifying pathogen sources and understanding transmission routes are essential components of the prevention and control of infections and disease.

Of the zoonotic sources of infection, cattle are recognised as a major contributor, because species and genotypes of *Cryptosporidium* and *Giardia* infecting humans have also been isolated from cattle (reviewed by [@bib408]). Although there is a considerable amount of information on *Cryptosporidium* and *Giardia* infections in cattle, little is known about them in other livestock animals. For instance, there have been only few molecular investigations of water buffalo (*Bubalus bubalis*) ([@bib20], [@bib56], [@bib110], [@bib151], [@bib219]), in spite of their importance as agricultural animals and their close association with humans in some countries.

Apart from their veterinary relevance relating to morbidity, mortality and production losses, *Cryptosporidium* and *Giardia* of domestic bovids receive major attention as zoonotic pathogens ([@bib313]). However, the prevalence of infections in human and animal populations and the extent of zoonotic transmission vary across different geographical regions of the world ([@bib109]). Most molecular studies of *Cryptosporidium* and *Giardia* have been conducted mainly in a limited number of countries in the developed world (reviewed by [@bib111], [@bib171]), and there is a paucity of information from other regions of the world, particularly in underprivileged countries.

The purpose of this article is to (1) provide a brief background on *Cryptosporidium* and *Giardia*, (2) concisely review aspects of the molecular epidemiology of cryptosporidiosis and giardiasis in animals, with an emphasis on bovines, (3) summarize some recent progress in research of *Cryptosporidium* and *Giardia* from bovines in parts of Australasia and Sri Lanka, considering public health aspects and (4) provide a perspective on future avenues of study.

2. Historical Perspective and Taxonomy {#s0015}
======================================

2.1. *Cryptosporidium* {#s0020}
----------------------

*Cryptosporidium* was first discovered by [@bib383]. He identified life cycle stages of a parasitic protist in the gastric glands of laboratory mice and proposed the name *Cryptosporidium muris* for this new species ([@bib384]). Subsequently, another new species, called *Cryptosporidium parvum*, was described by [@bib385]. *C. parvum* infected the small intestine, and the oocysts were smaller than those of *C. muris*. After its first discovery by Tyzzer, *Cryptosporidium* was not recognized as an economically or medically important parasite for the next 50 years. In 1955, it was first identified as a potentially disease-causing agent, when it was isolated from diarrhoeic turkeys ([@bib352]). In 1971, *Cryptosporidium* was reported to be associated with diarrhoea in young calves, for the first time ([@bib277]). Five years later, the first two human cases of cryptosporidiosis were reported ([@bib224], [@bib255]). Then, in 1982, the Centers for Disease Control (CDC) reported cryptosporidiosis in 21 HIV/AIDS patients in the USA ([@bib227]), after which *Cryptosporidium* received major attention around the world.

Traditionally, *Cryptosporidium* taxa have been identified based on oocyst morphology, host specificity and/or predilection site within the host ([@bib330]). Subsequently, using immunological or molecular methods, many distinct species and genotypes have been identified within *Cryptosporidium*. Over the years, the taxonomy of *Cryptosporidium* has undergone substantial change, leading to some controversies. The development of new molecular tools has allowed the identification and characterisation of species and/or genetic variants (genotypes) (reviewed by [@bib168], [@bib330]).

The genus *Cryptosporidium* belongs to the Phylum Apicomplexa, Order Eucoccidiorida and Family Cryptosporidiidae ([@bib106]). Presently, more than 26 species of *Cryptosporidium* have been recognised ([@bib70], [@bib330]). In addition, there are more than 40 genotypes that have not yet been formally recognised as species, because of a lack of sufficient morphological, biological and molecular data to comply with the International Code for Zoological Nomenclature (ICZN) rules of describing new species ([Table 1](#t0010){ref-type="table"} ) (cf. [@bib168], [@bib330]).Table 1Recognised species of *Cryptosporidium*SpeciesHost groupSite of infectionReferences*Cryptosporidium andersoni*CattleAbomasum[@bib207]*Cryptosporidium baileyi*BirdsBursa, cloaca, intestine[@bib79]*Cryptosporidium bovis*CattleIntestine[@bib103]*Cryptosporidium canis*CanidsIntestine[@bib104]*Cryptosporidium cuniculus*Rabbit, humanIntestine[@bib161][a](#t0010fna){ref-type="table-fn"}*Cryptosporidium fayeri*MarsupialsIntestine[@bib429]*Cryptosporidium felis*CatsIntestine[@bib164]*Cryptosporidium fragile*AmphibiansIntestine[@bib180]*Cryptosporidium galli*BirdsProventriculus[@bib281][b](#t0010fnb){ref-type="table-fn"}*Cryptosporidium hominis*HumansIntestine[@bib236]*Cryptosporidium macropodum*MarsupialsIntestine[@bib294]*Cryptosporidium meleagridis*Birds (humans)Intestine[@bib352]*Cryptosporidium molnari*FishesStomach[@bib16]*Cryptosporidium muris*RodentsStomach[@bib384]*Cryptosporidium parvum*Mammals (humans)Intestine[@bib385]*Cryptosporidium ryanae*CattleIntestine[@bib100]*Cryptosporidium scophthalmi*[c](#t0010fnc){ref-type="table-fn"}FishesIntestine[@bib15]*Cryptosporidium scrofarum*PigsIntestine[@bib189]*Cryptosporidium serpentis*SnakesStomach[@bib203]*Cryptosporidium suis*PigsIntestine[@bib328]*Cryptosporidium varanii*ReptilesIntestine[@bib282]*Cryptosporidium viatorum*HumansIntestine[@bib90]*Cryptosporidium wrairi*RodentsIntestine[@bib389]*Cryptosporidium xiaoi*SheepIntestine[@bib97][^1][^2][^3]

2.2. *Giardia* {#s0025}
--------------

Although *Giardia* was first observed in 1681 by Antonie van Leeuwenhoek, the first detailed description of this protist was not published until 1859. Subsequently, species of *Giardia* were described based on the host occurrence, because of a lack of characteristic or differentiating morphological features. Later, in 1952, an increasing number of *Giardia* species and uncertainty regarding host specificity led to a taxonomic rationalisation. Based on this classification, most members infecting vertebrates were named as one group, *Giardia duodenalis* ([@bib113]). Although this 'species' was isolated from humans and many animal hosts, the zoonotic significance of *Giardia* was controversial until the World Health Organization (WHO) recognised it as a zoonotic agent in 1979 ([@bib399]).

*Giardia* is a binucleate, flagellate protist belonging to Phylum Metamonada, Order Giardiida and Family Giardiidae ([@bib290]). Other recognised species of *Giardia* include *Giardia agilis*, *Giardia ardae*, *Giardia microti*, *Giardia muris* and *Giardia psittaci* ([Table 2](#t0015){ref-type="table"} ) ([@bib371]). At the trophozoite stage, they can be distinguished based on morphological characteristics using light and electron microscopy. *Giardia duodenalis* (syn. *Giardia intestinalis*, *Giardia lamblia*) is known to infect at least 40 host species, including humans ([@bib371]). The other species are known to be host specific or have a limited host range: *G. agilis* in amphibians, *G. ardae* and *G. psittaci* in birds and *G. microti* and *G. muris* in rodents ([@bib11]). Currently, *G. duodenalis* is recognised as a complex of at least eight different assemblages (A--H) ([@bib185], [@bib233]). Although there are little or no morphological differences, there is substantial genetic diversity among these assemblages ([@bib420], [@bib421]). Assemblages A and B are described to have a relatively broad host range, including humans and various other mammals. The other assemblages are either host specific or have narrow host ranges. Assemblages C and D are commonly found in dogs, whereas assemblage F mainly infects cats. Assemblage E is found in cloven-hoofed animals, and G is found in rodents ([@bib111], [@bib408]). Recently, assemblage H was identified in marine vertebrates ([@bib197]).Table 2Currently recognised species of *Giardia* and genetic groupings (assemblages) within *Giardia duodenalis*Species/assemblagesHostsG. duodenalisAssemblage AHumans, primates, dogs, cats, livestock, rodents, wild mammalsAssemblage BHumans, primates, dogs, cattle, some species of wild mammalsAssemblage CDogs, other canidsAssemblage DDogs, other canidsAssemblage ECattle and other hoofed livestockAssemblage FCatsAssemblage GRodentsAssemblage HMarine vertebrates*Giardia agilis*Amphibians*Giardia ardeae*Birds*Giardia microti*Rodents*Giardia muris*Rodents*Giardia psittaci*Birds

3. Life Cycles {#s0030}
==============

3.1. *Cryptosporidium* {#s0035}
----------------------

*Cryptosporidium* has a direct life cycle consisting of asexual and sexual reproductive phases ([@bib304]). The infective oocyst stage (4--6 μm) is excreted in the faeces from the infected hosts ([@bib187]). Susceptible hosts usually acquire infection by ingesting oocysts from contaminated water or food. Oocysts will then excyst at the predilection site in the host (gastrointestinal tract of mammals, birds and reptiles or respiratory tract of birds), and oocyst-derived sporozoites invade the epithelial cells and develop into trophozoites. Once they are intracellular, they start further development. Developing stages can be found in the extra-cytoplasmic, parasitophorus vacuoles in epithelial cells on the luminal surface ([@bib262]). Then, trophozoites undergo asexual reproduction (merogony or schizogony) to produce type I meronts (schizonts). Each of the type I meronts contains 16 merozoites, which are capable of invading new host cells to replicate and develop into a new type I or type II meronts. Type I meronts continue schizogony, and repeat the cycle, whereas type II meronts initiate sexual reproduction. Each of type II meronts contains four merozoites, each of which develops either into a microgamont (containing 12--16 microgametes; male) or a macrogamont (female). Mature microgametes are released and fertilize the unicellular macrogametes. Fertilized macrogametes develop into zygotes, which subsequently develop into oocysts, and four sporozoites develop within each oocyst ([@bib106], [@bib262]). There are two types of oocysts; thick-walled oocysts (80%) leave the host body with the faeces, whereas thin-walled oocysts (20%) can induce autoinfection directly the gut ([@bib141], [@bib187]).

3.2. *Giardia* {#s0040}
--------------

*Giardia* has a direct life cycle and reproduces by asexual replication (longitudinal binary fission) ([@bib10]). Infective stages (cysts) are excreted in the faeces from infected hosts into the environment. Following ingestion by a susceptible host, cysts enter the small intestine, where they excyst by the action of gastric acids and pancreatic enzymes ([@bib375]); the emerging trophozoites consume bile salts, causing deconjugation ([@bib350]). Each cyst produces two motile trophozoites, which are 12--15 μm long and 5--9 μm wide ([@bib10]). The trophozoites attach to the intestinal mucosa by their ventral sucking disc, a unique organelle composed of microtubules and tightly associated micro-ribbons ([@bib344]). The trophozoites usually colonize the duodenum and jejunum of the host and multiply by binary fission. Although it is widely accepted that *Giardia* reproduces by longitudinal binary fission, some studies have suggested that *Giardia* can reproduce sexually ([@bib41], [@bib371]). Some of the trophozoites encyst in the posterior intestine and are excreted as cysts in the faeces.

4. Transmission {#s0045}
===============

Generally, infective stages of *Cryptosporidium* and *Giardia* are excreted in the faeces from infected hosts, and are capable of infecting susceptible hosts following ingestion. Humans can acquire infection directly from contact with infected humans (anthroponotic transmission) or animals (zoonotic transmission), or indirectly from contaminated food or water sources ([@bib353]). *Cryptosporidium* oocysts and *Giardia* cysts are capable of remaining infective for long periods, particularly in cold and moist environments ([@bib354]). The microscopic size and low specific gravity of infective stages facilitate their dissemination in water ([@bib119]). These stages are resistant to most of the routine disinfection methods used for drinking water, swimming pools and irrigation systems ([@bib119]). Both *Cryptosporidium* and *Giardia* can infect their hosts at very low doses (\<10 oocysts/cysts) ([@bib268], [@bib306]). Among different *Cryptosporidium* species infecting humans, *C. parvum* has a broad host range, including livestock, companion animals and wild animals; therefore, it can be transmitted via both anthroponotic and zoonotic routes ([@bib58]). In contrast, *Cryptosporidium hominis* primarily infects humans, although experimental ([@bib135]) and natural infections in livestock ([@bib355]) and other animals ([@bib238]) have been reported in some instances. Therefore, with few exceptions, *C. hominis* is usually transmitted by anthroponotic pathways ([@bib168]). Epidemiological and genetic studies of *Cryptosporidium* and *Giardia* isolates from different sources have enhanced knowledge of transmission routes and animal reservoirs.

Different species of *Cryptosporidium*, including *C. parvum*, *C. hominis* and *Cryptosporidium meleagridis*, have been identified from human cases associated with waterborne cryptosporidiosis outbreaks. According to a review ([@bib28]), *Cryptosporidium* and *Giardia* have been responsible for 120 (60.3%) and 70 (35.2%) of 199 waterborne outbreaks from 2004 to 2010. Many of these waterborne outbreaks have been reported from New Zealand (40.2%), followed by North America (30.6%) and Europe (16.5%). In contrast, 3.5% of outbreaks have been reported from developing countries in Asia ([@bib28]). However, the greater number of waterborne outbreaks in developed countries is likely due to advanced reporting and surveillance systems, rather than to a higher prevalence of infections. Furthermore, a review of environmental transmission of *Cryptosporidium* and *Giardia* infections in humans has reported that *C. hominis* was responsible for more cryptosporidiosis outbreaks than *C. parvum* (see [@bib354]). However, this interpretation might be biased in that the majority of data were from developed countries, where many infections are likely acquired anthroponotically via swimming pools and/or daycare centres ([@bib406]).

Foodborne transmission of cryptosporidiosis and giardiasis has also been reported on a number of occasions, due to the consumption of contaminated food. Use of fertilizer produced from livestock waste, surface run-off from feedlots and untreated water used for irrigation can lead to the contamination of food with infective stages. Food may also be contaminated during harvesting, packing, transportation, selling and/or preparation under unhygienic conditions ([@bib91], [@bib316]). Various studies have isolated oocysts and cysts from different fresh produce, including water spinach, lettuce, Chinese cabbage, potatoes and carrots ([@bib19], [@bib21], [@bib232], [@bib367], [@bib393]). Other studies have examined the presence of *Cryptosporidium* and *Giardia* in water used for irrigation and food production or packing, and have demonstrated that contaminated water is a major source of oocysts or cysts in fresh produce ([@bib66], [@bib376]). In addition, it has been shown that such infective stages are capable of remaining viable in stored fresh food for long periods ([@bib212], [@bib376]).

An investigation of the efficacy of different treatments used in food processing (i.e. chlorine, blanching, blast freezing and microwave heating) on the viability of *C. parvum* has showed that oocysts can be destroyed by heat and, to some extent, by freezing, but not by safe concentrations of chlorine ([@bib83]). Usually, *Giardia* cysts are more susceptible to chlorine disinfection than *Cryptosporidium* oocysts ([@bib363]). *Giardia* cysts tend to have shorter longevity in the environment. In one study, *Giardia* cysts were shown to survive at -4 °C in water and soil for \<1 week, whereas *Cryptosporidium* oocysts survived for \>12 weeks ([@bib269]). Nonetheless, the persistence of these oocysts/cysts in water, soil or in/on food suggests that the consumption of fresh produce, which receives minimal washing and heat treatment, can pose an infection risk. With the increasing number of outbreaks and sporadic cases associated with *Cryptosporidium* and *Giardia*, new techniques have been developed for the concentration and detection of *Cryptosporidium* and *Giardia* oocysts/cysts in food produce ([@bib76]). Although these techniques have been able to recover *Cryptosporidium* and *Giardia* from contaminated foods, the occurrence of these protists might be underestimated, because of the suboptimal efficacy or sensitivity of the methods used ([@bib77]).

In animals, *Cryptosporidium* and *Giardia* infections also can occur via multiple pathways. For instance, infections can spread among calves by direct contact or indirectly via utensils or udders contaminated with calf faeces containing oocysts/cysts ([@bib134]). Because young animals are usually more susceptible to *Cryptosporidium* and *Giardia*, they can act as a major source of infections to other animals ([@bib218]). Inadequate hygiene and poor husbandry practices are significant contributors to the high prevalence of *Cryptosporidium* and *Giardia* infections in cattle herds. Generally, intensive management systems on dairy farms can increase the transmission of infections among calves, when young animals are kept at high density ([@bib134]). The introduction of infective stages from wild animals is another potential route of infection for domestic animals ([@bib168]).

5. Epidemiology {#s0050}
===============

*Cryptosporidium* and *Giardia* are major causes of parasitic diarrhoea in humans and animals globally ([@bib222], [@bib345]). Disease surveillance projects have provided epidemiological information on the prevalence of cryptosporidiosis and giardiasis in relation to demographic features, such as age, sex and geographical location. However, information on the epidemiology of these diseases is limited in developing countries compared with developed countries, mainly because of poor health care and reporting systems, and a lack of diagnostic facilities and tools.

Sources and transmission of *Cryptosporidium* and *Giardia* can be difficult to establish because of the ubiquitous nature and the multiple routes of transmission of these protozoan parasites. Based on the analyses of outbreaks, the incubation period of cryptosporidiosis varies, but has been reported to be within 5--7 days in many cases, depending on the immune status of the host and the dose of infective stages ([@bib34], [@bib65], [@bib163], [@bib226], [@bib249], [@bib413]). The duration of symptoms in cryptosporidiosis outbreaks has been reported to commence at 5--9 days (range: 2--13), following the ingestion of infective stages ([@bib254]). In *Giardia*, the incubation period can range from 3 days to 6 weeks ([@bib371]). Prospective and retrospective serological surveys (in spite of diagnostic test performance issues; [@bib250]) have been used to estimate seroprevalence and the risk of infections in human populations. However, the reported seroprevalence is highly variable, and depends on many factors including social and hygienic conditions and geographical location ([@bib386]). Low seroprevalence in communities can be predictive of a high infection rate in outbreak situations ([@bib254]). In contrast, a high seroprevalence might indicate a high rate of immunity in a population ([@bib386]).

According to epidemiological studies ([@bib42], [@bib114], [@bib129], [@bib159], [@bib320]), high risk groups for cryptosporidiosis and giardiasis usually include infants, young children and staff in daycare centres, immunocompromised people (e.g. HIV/AIDS, solid organ and bone marrow transplant patients), farmers, animal handlers and international travellers ([@bib316]). HIV-infected people are particularly susceptible to a number of *Cryptosporidium* species and genotypes, and can develop chronic and severe infections ([@bib159]). High rates of infections in young children can be related to exposure as well as reduced immune status ([@bib254]). Therefore, protection of these vulnerable populations is important for the prevention of disease transmission. Asymptomatic infections of *Cryptosporidium* and *Giardia* are also common in humans, particularly in endemic areas in developing countries ([@bib67], [@bib80], [@bib93], [@bib274]). Therefore, some individuals can act as asymptomatic carriers for other family members and people in the same community ([@bib274]).

Based on the results of epidemiological studies, a number of risk factors have been associated with cryptosporidiosis and giardiasis in humans. For instance, case--control studies conducted in Australia ([@bib310]), the UK ([@bib158]) and the USA ([@bib324]) have described that contact with infected persons, particularly young children with diarrhoea, is a major risk factor for sporadic cryptosporidiosis. Other risk factors associated with sporadic cryptosporidiosis include travelling abroad, swimming in fresh water and contact with cattle ([@bib158], [@bib310], [@bib324]). Studies conducted in developing countries (e.g. [@bib1], [@bib182], [@bib230]) have identified multiple risk factors for cryptosporidiosis, including young age (\<2 years), rainy season, absence of breast feeding, contact with pets, overcrowded living conditions, low birth weight, malnutrition and/or coinfections with other pathogens (e.g. malaria).

Cryptosporidiosis and giardiasis have also been reported to display temporal variation in human and animal populations. Generally, a high prevalence of parasitic infections is reported in warmer and wetter months of the year ([@bib283]). A recent review of the seasonality of enteric zoonotic diseases in Australasia, Europe and North America ([@bib191]) has reported that there is a bimodal pattern of human cryptosporidiosis cases in spring and late summer--early autumn. Similarly, high incidences of giardiasis have been observed in summer in Canada, the UK and the USA. In tropical climates, the number of cryptosporidiosis cases has been reported to be higher in hot and humid months in the rainy season ([@bib248], [@bib305]).

6. Pathogenesis of Disease and Clinical Manifestation {#s0055}
=====================================================

*Cryptosporidium* and *Giardia* primarily infect the gastrointestinal tracts of a wide variety of vertebrates including mammals, birds and reptiles. In addition, *Cryptosporidium* is known to cause respiratory or renal infections in birds ([@bib262], [@bib326]). Usually, *Cryptosporidium* invades the epithelial cells of the terminal jejunum and ileum in immunocompetent people ([@bib187]), but can affect the entire gastrointestinal tract, including bile and pancreatic ducts, in immunocompromised individuals ([@bib159]). Epithelial destruction due to parasite invasion and inflammatory reactions in the intestine leads to villous atrophy and fusion, which causes malabsorption and diarrhoea in cryptosporidiosis ([@bib187], [@bib372]). *Giardia* usually colonises the duodenum and jejunum of the small intestine. It has been shown that *Giardia* causes strain-dependent induction of enterocyte apoptosis, which may lead to the loss of function of epithelial barrier and increased permeability ([@bib72]). In addition, it has been shown that hypersecretion of chloride is responsible for the accumulation of fluid in the intestinal lumen in chronic giardiasis ([@bib377]).

Clinical manifestations and patterns of oocyst excretion in patients with cryptosporidiosis depend on host factors (including immune status) as well as the pathogen species, variant, virulence, origin and/or infective dose ([@bib138], [@bib268]). Cryptosporidiosis in immunocompetent individuals is usually self-limiting and lasts for 5--10 days ([@bib279]). In addition, fever, nausea, anorexia, fatigue, abdominal cramps and vomiting are also common ([@bib187], [@bib215]). Infection in immunocompromised individuals (e.g. HIV-infected patients, malnutrition and/or defects in the CD40-CD154 system) may lead to chronic enteritis/diarrhoea and sometimes death ([@bib159]). Based on the results of in vivo and in vitro studies, both innate and adaptive immunities are involved in host defences against cryptosporidiosis ([@bib271], [@bib279]). Mucosal epithelial cells provide initial defence against *Cryptosporidium* infection by producing different inflammatory mediators, such as antimicrobial peptides (e.g. β-defensins), inflammatory chemokines and cytokines ([@bib271]). These chemokines/cytokines then activate and mobilise the immune effector cells (e.g. neutrophils, lymphocytes and macrophages). The adaptive immunity is activated by recognition of specific antigens by T-cells and B-cells. Cell-mediated immunity involving CD4^+^ T-cells and IFN-γ plays a major role in adaptive immunity ([@bib45]). Mucosal antibodies are also involved in the control of infection. Therefore, both humoral and cellular components of immunity play a role in the control of cryptosporidiosis.

*Giardia* infections can be asymptomatic or can cause a severe malabsorption syndrome, depending on the immune status of the host ([@bib95]). Clinical signs of giardiasis include acute or chronic diarrhoea, abdominal pain, nausea, vomiting and weight loss ([@bib85]). Pathophysiological consequences of giardiasis are multifactorial and depend on both host and parasite factors ([@bib78]). The attachment of *Giardia* trophozoites to intestinal epithelial cells activates a series of events that leads to diarrhoea by increasing rates of enterocyte apoptosis, small intestine barrier dysfunction, anion hypersecretion, lymphocyte activation, shortening of brush border microvilli and/or malabsorption ([@bib78]). Host defence against *Giardia* involves a number of immunological and non-immunological events in the gut mucosae ([@bib323]). The intestinal epithelium plays a major role in innate and adaptive immunity in giardiasis ([@bib323]). Studies conducted using laboratory mice have demonstrated that IL-6 is important for clearance and control of acute infections ([@bib419]).

Cryptosporidiosis in cattle is typically symptomatic in neonates and pre- and postweaned calves, but adults are usually asymptomatic ([@bib304]). *Cryptosporidium parvum* causes high morbidity linked to profuse diarrhoea in preweaned calves. Sometimes infection can lead to death in severely affected animals. Older calves and adults are usually infected with host-adapted species of *Cryptosporidium* including *Cryptosporidium bovis*, *Cryptosporidium andersoni* and *Cryptosporidium ryanae* (see [@bib313]). Although giardiasis in ruminants is often asymptomatic, diarrhoea, lethargy and poor weight gain in calves can lead to production losses and/or deaths ([@bib266]). The duration of infection can range from a few days to several months, and intermittent excretion of *Giardia* cysts has been observed in both humans and animals ([@bib371]). Also dogs and cats may develop acute or chronic self-limiting diarrhoea. Asymptomatic infections are also common in various companion animals ([@bib375]). Clearly, understanding host responses against *Cryptosporidium* and *Giardia* infections could provide a foundation for the development of novel intervention strategies ([@bib271]).

7. Aspects of Treatment, Prevention and Control {#s0060}
===============================================

Although *Cryptosporidium* and *Giardia* infections are often self-limiting in humans and animals, treatments can help control disease and its complications. Although more than 100 compounds have been tested for treating cryptosporidiosis in humans, only a few of them can reduce the severity of symptoms, including paromomycin, azithromycin and nitazoxanide ([@bib199]). However, there was no registered therapeutic agent for treating cryptosporidiosis in humans until nitazoxanide was licensed in the USA ([@bib322]). Halofuginone, a synthetic product of quinazolinone group, is known to have therapeutic effect against clinical signs of cryptosporidiosis, particularly in ruminants ([@bib166]). For example, a study of the efficacy of halofuginone lactate against cryptosporidiosis in calves reported a reduction in oocyst excretion and diarrhoea, and delayed the onset of infection in calves exposed to challenge infection with *C. parvum* (see [@bib200]). On the other hand, a number of therapeutic agents, including nitroimidazole derivatives (e.g. metronidazole, tinidazole and ornidazole), nitrofuran and benzimidazole drugs have been shown to be effective against *Giardia* in both humans and animals ([@bib94]). However, metronidazole has been the most commonly used drug for treating giardiasis for the past 40 years. Metronidazole treatment failures against giardiasis have been reported; although metronidazole resistance can be readily induced in *G. duodenalis* in vitro, little is known regarding the extent and spread of resistance in natural populations of this protist ([@bib242]). Interestingly, nitazoxanide is the first new compound developed for treating giardiasis in more than 20 years ([@bib322]), but its efficiency and safety are controversial ([@bib152]).

Although there are different treatment options available, prevention is the most effective means of protecting humans and animals from *Cryptosporidium* and *Giardia* infections. Identifying sources, routes of transmission and risk factors are key requirements for the prevention and/or control of these parasites. Because of the robust nature and low infective doses of *Cryptosporidium* and *Giardia*, prevention and control are challenging, and management components are critical ([@bib58]). In humans, control measures should essentially include good hygiene and avoiding the ingestion of contaminated water and/or food. Because of the frequent detection of zoonotic *Cryptosporidium* and *Giardia* in water, it is important to maintain water quality by protecting water catchments and interventions via water treatment processes, in order to prevent waterborne outbreaks. Many major cities in developed countries have ongoing monitoring programs for the detection of *Cryptosporidium* and *Giardia* in catchments and drinking water ([@bib108], [@bib258]). In contrast, people in most of the countries in the developing world do not have access to clean and safe drinking water ([@bib358]). People in such countries use water from irrigation canals, unprotected wells, boreholes and public standpipes for drinking and other household requirements ([@bib74], [@bib346]). Therefore, in such regions, various household water treatment methods, such as boiling and filtration, can be used to remove or inactivate the infective stages of *Cryptosporidium* and *Giardia* from/in water ([@bib358]).

Cryptosporidiosis and giardiasis of livestock are also controlled through proper management and husbandry practices. Because of the presence of infective stages in faeces, manure and sewage management is crucial for disease prevention and control. The measures used to prevent or reduce transmission from animal-to-animal and farm-to-farm include good hygiene (regular cleaning of pens, proper disposal of faecal waste and disinfection of utensils), proper management (avoiding overcrowding, keeping young and adult animals in separate areas and ensuring that newborn animals receive immediately an adequate amount of colostrum), prevention of concurrent infections and early diagnosis and treatment of infected animals (e.g. [@bib168]). Because of the high prevalence of *C. parvum* reported for preweaned calves, additional measures need to be taken into account to control diarrhoea and prevent transmission to humans. According to a study conducted in dairy cattle herds in Canada ([@bib378]), removing neonatal calves from the dam within 1 h of birth, while providing adequate initial colostrum, and calving in winter months may decrease the risk of neonatal diarrhoea. Keeping calves in individual pens and using an 'all-in-all-out' management strategy ([@bib348]) also decrease the risk of transmission and the rapid spread of disease ([@bib62], [@bib217]).

8. Brief Account of *Cryptosporidium* and *Giardia* of Humans {#s0065}
=============================================================

*Cryptosporidium* and *Giardia* are frequent causes of gastrointestinal infections in humans worldwide. Both parasites are considered as significant waterborne pathogens due to their ubiquitous nature, frequent association with waterborne outbreaks and their resistance to most of the disinfectants used in water treatment ([@bib342]. *Giardia* is the most commonly diagnosed intestinal parasite of humans, with more than 2.5 × 10^8^ cases estimated annually (e.g. [@bib194]). According to an estimation by the Centers for Disease Control and Prevention (CDC), the number of giardiasis cases in the USA is ∼2 million per year ([@bib416]). It has been estimated that ∼200 million people have symptomatic giardiasis in Asia, Africa and Latin America, with some 500,000 new cases reported each year ([@bib53]). Cryptosporidiosis is also global in distribution. It has been suggested that cryptosporidiosis is responsible for up to 20% of all cases of childhood diarrhoea in developing countries ([@bib222], [@bib241], [@bib312]).

Most human cryptosporidiosis cases are due to *C. hominis* and/or *C. parvum* (See [@bib54]), although some are attributed to *Cryptosporidium canis*, *Cryptosporidium felis* and *C. meleagridis*, *Cryptosporidium suis* and 'cervine and monkey' genotypes (which usually infect animals) ([@bib407]), and have been reported mainly from immunocompromised (e.g. HIV-infected) or -suppressed patients ([@bib61], [@bib237]). Interestingly, *Cryptosporidium cuniculus*, usually a parasite of rabbits, is genetically closely related to *C. hominis* and *C. parvum*, and has been responsible for outbreaks of cryptosporidiosis in humans in the UK ([@bib68], [@bib298], [@bib319]). The only species of *Giardia* infecting humans is *G. duodenalis* (syn. *G. lamblia* and *G. intestinalis*). Human infections due to *G. duodenalis* assemblages A and B have been reported, with variable prevalences in different countries (reviewed in [@bib57]). Based on molecular epidemiological data, it has been suggested that *G. duodenalis* assemblage B, which is believed to be anthroponotic, constitutes a greater public health risk than assemblage A, which is zoonotic and particularly prevalent in cattle ([@bib58]).

Although cryptosporidiosis and giardiasis have been reported globally, the prevalences of infections appear vary considerably, depending on geographical region. For example, the prevalence of cryptosporidiosis in asymptomatic people (immunocompetent and healthy individuals) has been estimated to range from 0% to 6.4% in developed countries, and from 2.3% to 7.5% in developing countries (reviewed in [@bib168]). A higher prevalence of infections in developing countries might be due to the poor sanitation, poverty and lack of diagnostic and treatment facilities ([@bib299]). Studies conducted in developing countries have reported that cryptosporidiosis is common in children younger than 5 years, with the highest prevalence in children of less than 2 years of age ([@bib35], [@bib36], [@bib40], [@bib284], [@bib366]). However, detailed information allowing meaningful interpretation of the epidemiology of cryptosporidiosis and giardiasis from developing countries is very limited. The Malnutrition and Enteric Disease (MAL-ED) project was developed to significantly enhance the knowledge of these diseases in developing countries and has highlighted their major contribution to the global burden of diarrhoeal diseases ([@bib222]). However, no detailed information is available from developing countries for a meaningful interpretation of the epidemiology of cryptosporidiosis and giardiasis.

In contrast, better statistics are available for many developed countries ([@bib140]). Marked seasonal patterns of *Cryptosporidium* and *Giardia* infections have been observed in a number of developed countries, including Australia, Canada, New Zealand ([@bib357]), the UK ([@bib223]) and the USA ([@bib417]). A recent review, which analysed information on patterns of important human enteric zoonotic diseases in temperate climatic zones in developed countries ([@bib191]), reported that there is a clear (bimodal) peak of cryptosporidiosis cases in spring and summer seasons. In contrast, giardiasis showed a relatively small peak in summer ([@bib191]). Critically, from a disease burden perspective, the majority of studies in developed and developing countries are cross-sectional surveys, and a greater focus on longitudinal cohort studies is needed ([@bib222]), particularly considering that many of the health impacts of these pathogens are believed to be chronic and extend beyond the patency of infection ([@bib142], [@bib147]).

Interestingly, most of the outbreaks associated with drinking and recreational waters have been reported from developed countries. According to the literature, from 1984 to 1996, there were 19 documented cryptosporidiosis outbreaks affecting more than 427,000 individuals ([@bib356]), the largest being the outbreak in Milwaukee (USA) in 1993. An appraisal of waterborne outbreaks of parasitic protozoan diseases ([@bib181]) indicates that North American and European countries accounted for 93% of the 325 reported water-associated outbreaks; *Cryptosporidium* and *Giardia* were responsible for 165 and 132 outbreaks, respectively ([@bib181]). These numbers reflect an ascertainment bias for developed countries, with the greater resources to track outbreaks of cryptospordiosis and giardiasis.

In addition, foodborne outbreaks of cryptosporidiosis and giardiasis have also been reported from developed and developing countries, due to the consumption of fresh vegetables, salads and fruits contaminated with infective stages of *Cryptosporidium* and *Giardia* ([@bib80]). Therefore, understanding the molecular epidemiology of human cryptosporidiosis and giardiasis is important for the prevention and control of diseases caused by these two parasitic diseases in both developed and developing countries. The identification of potential infection sources, awareness of important preventive measures (hygiene and behavioural practices) and improved water treatment and disinfection strategies can aid in preventing disease transmission to humans ([@bib168]).

9. *Cryptosporidium* and *Giardia* of Animals, with an Emphasis on Bovines {#s0070}
==========================================================================

*Cryptosporidium* and *Giardia* have been recorded in a wide variety of animals including mammals, birds, reptiles, amphibians and fishes ([@bib11], [@bib262], [@bib330] [@bib414]). Currently, more than 150 mammalian species have been identified as hosts for various *Cryptosporidium* species ([@bib330]). Generally, young animals are more susceptible to cryptosporidiosis and giardiasis than adults. Most *Cryptosporidium* species are infective to a range of host species, while some are host specific. *Cryptosporidium* and *Giardia* infections have increasingly been recorded in livestock animals, particularly cattle. In young calves, high morbidity caused by *Cryptosporidium* and *Giardia* can lead to substantial production losses to the livestock industry ([@bib141]). According to studies conducted in dairy and beef cattle, cryptosporidiosis is mostly detected in dairy calves from 8 to 15 days of age, and in beef calves from 1 to 2 months of age ([@bib304]). *Cryptosporidium parvum* and *G. duodenalis* (assemblages A and B) have been identified as potentially zoonotic, because these species/genotypes/assemblages are also capable of infecting humans. Among other livestock animals, *C. parvum* has been reported from lambs and goat kids of less than 3 months of age ([@bib64], [@bib132], [@bib273], [@bib339]). However, the extent of zoonotic transmission of cryptosporidiosis or giardiasis from lambs and goat kids is unclear, given limited studies of these animals ([@bib315], [@bib331]). In sheep, *Cryptosporidium ubiquitum*, *Cryptosporidium xiaoi* and *C. parvum* have been reported relatively frequently, whereas for goats, species and genotypes of *Cryptosporidium* are not comprehensively documented ([@bib336]). Cryptosporidiosis and giardiasis in pigs and horses are often asymptomatic, even though there were some reports of disease in very young animals ([@bib425], [@bib428], [@bib432], [@bib410]).

Evidence for zoonotic transmission of *Cryptosporidium* and *Giardia* infections from companion animals is limited ([@bib276]). Dogs and cats are primarily infected with host-adapted species and genotypes; therefore, the actual risk of zoonotic transmission from companion animals appears to be minimal ([@bib210]). *Cryptosporidium* infection in dogs is usually due to *C. canis* (see [@bib3], [@bib276]), although *C. parvum* has been detected in some studies ([@bib2]). Cats are usually infected with *C. felis*, which is also host specific ([@bib101], [@bib240]). Giardiasis of dogs is commonly caused by *G. duodenalis* assemblages C and D ([@bib4], [@bib359]). However, *G. duodenalis* assemblage A has been reported in dogs from Germany ([@bib202]), Mexico ([@bib192]) and Brazil ([@bib392]). Giardiasis of cats is often due to *G. duodenalis* assemblage F, but *G. duodenalis* assemblage A has also been reported infrequently ([@bib359]). Case--control studies conducted in Australia, the UK and the USA ([@bib158], [@bib310]) have found that there is a negative association between sporadic cryptosporidiosis and contact with domestic pets. There are some studies of *Cryptosporidium* and *Giardia* in wild animals ([@bib32], [@bib33], [@bib288], [@bib307]). The potentially zoonotic species of *Cryptosporidium* and *G. duodenalis* (assemblages A and B) have been reported from wild animals including artiodactyles, rodents, primates and carnivores (reviewed by [@bib24]). However, the role of wild animals in the zoonotic transmission of cryptosporidiosis and giardiasis to humans is still unclear, because limited information is available for different host species, and most studies to date have not used molecular techniques for the identification and genetic characterisation of isolates (e.g. [@bib24], [@bib304], [@bib408]).

9.1. Cattle {#s0075}
-----------

*Cryptosporidium* and *Giardia* are two of the commonest parasitic protists infecting cattle of all age groups ([@bib270]). Clinical signs in infected animals can vary from acute to chronic diarrhoea, which often leads to anorexia, weight loss, ill thrift and sometimes death ([@bib270], [@bib373]). Cattle can harbour a number of *Cryptosporidium* species/genotypes and *G. duodenalis* assemblages. Currently, *C. andersoni*, *C. bovis*, *C. ryanae* and *C. suis* have been commonly reported from cattle ([@bib336]). In addition *C. canis*, *C. felis*, *C. hominis*, *C. suis*-like genotype and pig genotype II have been reported sporadically ([@bib379]). For *G. duodenalis*, assemblages A, B and E are known to infect cattle ([@bib134], [@bib370]). *G. duodenalis* assemblage E has been reported at a higher prevalence than assemblage A ([@bib408]), whereas assemblage B has been less commonly reported ([@bib48], [@bib75], [@bib193], [@bib208], [@bib402]).

Most dairy calves seem to be infected with *Cryptosporidium* and/or *Giardia* during the first few months of life, but only some animals develop diarrhoea ([@bib265], [@bib263], [@bib302]). Although *Cryptosporidium* and *Giardia* infect cattle of all ages, various studies have reported an age-related variation of *Cryptosporidium* species in cattle ([@bib102], [@bib99], [@bib190], [@bib341]). *Cryptosporidium parvum* is usually predominant in preweaned calves (\<3 months); *C. bovis* and *C. ryanae* are common in postweaned calves, whereas *C. andersoni* is commonly isolated from older calves and adult cattle ([@bib47], [@bib82], [@bib341]). Based on longitudinal and cross-sectional surveys of bovine cryptosporidiosis, the highest rates of *Cryptosporidium* infection have been reported in calves of 1--3 weeks of age ([@bib31], [@bib63], [@bib156], [@bib338]). Furthermore, it has been reported that, in calves, the shedding of *Cryptosporidium* oocysts in faeces starts as early as 2 days of age and can peak around 14 days of age ([@bib270]). Therefore, it is believed that calves might acquire infection during or shortly after birth ([@bib410]). Usually, oocyst shedding occurs within a relatively short period, lasting for 4--16 days ([@bib96]). Although there is an apparent age-related distribution ([@bib408]), *Giardia* has been mostly recorded in calves of 1--6 months of age, rather than animals of \>6 months of age (reviewed in [@bib134]). The prevalence of *Giardia* in calves of \<6 months has been reported to be 20--73% globally ([@bib131]). However, *Giardia* has been detected in dairy calves as early as 3 days of age in some studies ([@bib405]). Based on longitudinal and cross-sectional surveys of bovine cryptosporidiosis, the highest rates of *Cryptosporidium* infection have been found in calves of 1--3 weeks of age ([@bib31], [@bib63], [@bib156], [@bib338]).

Infections of cattle with *Cryptosporidium* species and *G. duodenalis* assemblages of zoonotic potential (i.e. *C. parvum* and *G. duodenalis* assemblages A and B) have been frequently reported, indicating that cattle are a reservoir for human cryptosporidiosis and giardiasis (e.g. [@bib160], [@bib327]). Contact with infected calves has been identified as a main reason for a number of small cryptosporidiosis outbreaks in veterinary students ([@bib118], [@bib292], [@bib295]), research technicians and children attending agricultural camps ([@bib426], [@bib431]), providing evidence for zoonotic transmission of cryptosporidiosis from cattle. In addition, case--control studies have reported that contact with cattle is a significant risk factor for sporadic cryptosporidiosis in humans ([@bib158], [@bib310], [@bib324]).

*Giardia duodenalis* assemblage A is increasingly being detected in cattle (reviewed in [@bib327]). For example, this assemblage has been reported at prevalences of 43--70% of cattle in the USA ([@bib340]) and Canada ([@bib433]). A recent review ([@bib327]) on zoonotic transmission of *Giardia* has reported that the prevalence of assemblage A in France, Germany, Italy and the UK ranged from 28% to 61%. However, by contrast, most of the studies of bovine giardiasis in Australia, Europe and North America have reported that the livestock-specific assemblage E is predominant in cattle ([@bib31], [@bib195], [@bib340], [@bib380], [@bib381]), except in New Zealand, where assemblages A and B appear to be common, and assemblage E was reported to be largely absent from cattle ([@bib111]). It has been estimated that ∼80% of *Giardia* infections in dairy cattle and 98% in beef cattle are due to assemblage E (reviewed in [@bib266]). Thus, it has been suggested that the public health risk of bovine giardiasis is minimal, at least in the countries where assemblage E is the predominant genotype ([@bib58]). Mixed infections of assemblages A and E have also been reported frequently in cattle ([@bib131], [@bib184], [@bib340]). Furthermore, longitudinal studies of cattle have indicated that infections of zoonotic genotypes of *Giardia* in cattle might be transient and, when the frequency of transmission with assemblage E is high, a competition of genotypes might occur ([@bib31], [@bib111]).

Recently, molecular tools using markers in the 60 kDa glycoprotein (*gp60*) gene have improved the ability of identifying and differentiating zoonotic *Cryptosporidium* at the genotypic and subgenotypic levels. Such tools can be applied to investigate the distribution of *C. parvum gp60* variants in cattle and human populations in different geographical regions ([@bib313]). Based on *gp60* gene sequence data, *C. parvum* genotype IIa was the commonest genotypes found in cattle globally (reviewed in [@bib171]). Many of the IIa subgenotypes detected in cattle have also been found in humans ([@bib408]). For example, several studies conducted in Australia, Canada and Portugal have isolated the same *C. parvum* subgenotypes from cattle and humans in the same regions ([@bib18], [@bib49], [@bib251]), which indicates *C. parvum* transmission between human and cattle populations in those regions.

Usually, infected animals excrete as many as 10^6^--10^7^ oocysts/cysts per gram of faeces, which can massively contaminate the environment, even in the situation of a low prevalence of infection ([@bib313], [@bib371]). Surface water and groundwater sources can be contaminated by these infective stages from run-off from farm paddocks. Therefore, these stages can ultimately contaminate food and water sources used for human consumption ([@bib304]). *Cryptosporidium* and *Giardia* oocysts/cysts have been isolated from fresh fruits and vegetables in studies conducted, for example, in Costa Rica ([@bib231], [@bib232], [@bib60]), Peru ([@bib275]) and Norway ([@bib317], [@bib311]). Although the sources of infective stages were not identified in these studies, cattle were suspected as a source in some instances, because molecular detection has revealed that the subgenotypes found in the infected humans and food are common also in cattle ([@bib43], [@bib353]). In addition, a small outbreak of cryptosporidiosis occurred following the consumption of unpasteurized cow\'s milk (due to poor udder hygiene), which also provides evidence for zoonotic transmission ([@bib149]).

Although many studies of cryptosporidiosis and giardiasis in cattle have been conducted, most of them have been on dairy farms, whereas only a small number of studies have focused on beef cattle ([Table 3](#t0020){ref-type="table"} ). Few studies have used molecular diagnostic tools to identify and differentiate the species/genotypes infecting beef cattle. However, *C. parvum* and *G. duodenalis* assemblages A and B have been reported from beef animals ([@bib25], [@bib48], [@bib130], [@bib131], [@bib251]). Studies conducted in Canada and the USA have reported prevalences of *Cryptosporidium* infection in beef cattle of 7.1--43% ([@bib25], [@bib48], [@bib98], [@bib139], [@bib221]). On the other hand, the prevalence of *Giardia* infection ranged between 6.5% and 34% ([@bib48], [@bib155], [@bib221]). Very little information is available on cryptosporidiosis in beef cattle for other countries. Studies have suggested that beef cattle are of limited significance in the zoonotic transmission of *Giardia* relative to dairy cattle ([@bib155]). The prevalence of *G. duodenalis* assemblage E, which is not typically zoonotic, is high (≤100%) in both beef and dairy cattle ([@bib23], [@bib252], [@bib380], [@bib382]). In contrast, however, *G. duodenalis* A, which is zoonotic, is reportedly much less prevalent in beef relative to dairy cattle ([@bib23], [@bib81], [@bib131]). Caution in the interpretation of this information is warranted, as there are limited molecular investigations of beef cattle, particularly for *Cryptosporidium* ([@bib48], [@bib98], [@bib107], [@bib133]), and the extent to which these studies are representative of beef cattle generally is not yet established.Table 3Studies of *Cryptosporidium* and *Giardia* in beef cattleCountryHost ageTotal numberMolecular marker(s), *Cryptosporidium* species or genotype (% of positive)Molecular marker(s), *Giardia duodenalis* assemblage (% of positive)ReferencesAustralia≤3 or 3--9 months201SSU-rRNA and *gp60*\
*Cryptosporidium parvum* 3%\
*Cryptosporidium bovis* 10%\
*Cryptosporidium ryanae* 3%*tpi*\
Assemblage A 1%\
Assemblage E 24%[@bib5]Belgium\<10 weeks333--β-giardin[@bib131]Assemblage A 16%Assemblage E 84%*tpi*Assemblage A 6%Assemblage E 71%Mixed A and E 22%Canada\<6 months739SSU-rRNA and *hsp70*SSU-rRNA and β-giardin[@bib48]\>6 months*C. parvum* 24%Assemblage A 4%*C. bovis* 20%Assemblage B 7%*C. ryanae* 7%Assemblage E 89%*Cryptosporidium andersoni* 49%CanadaPooled manure samples from different ages112SSU-rRNA and *hsp70*SSU-rRNA and β-giardin[@bib81]*C. andersoni* 100%Assemblage E 100%Japan2 months to 15 years113SSU-rRNA[@bib244]*C. bovis* 13%*C. ryanae* 5%Mixed *C. bovis* and *C. ryanae* 2%USACalves (6--8 months) and cows (\>2 years)212SSU-rRNA--[@bib107]*C. bovis* 9.4%*C. andersoni* 1.4%*Cryptosporidium* deer-like genotype 6.6%USA6--18 months819SSU-rRNA--[@bib98]*C. andersoni* 68%*C. bovis* 23%*C. ryanae* 9%USA6--18 months819--SSU-rRNA[@bib337]Assemblage E 31.5%Assemblage A 1.2%Vietnam2--6 months232SSU-rRNA--[@bib253]*C. bovis* (0.8%)*C. ryanae* (3.9%)Zambia2--70 days238SSU-rRNA--[@bib133]*C. parvum* 2.9%*Cryptosporidium suis* 0.4%*hsp70C. parvum* 1.3%*C. suis* 0.4%

A review of *gp60* sequence data for *Cryptosporidium* ([@bib171]) reported that the information on cattle originated mainly from 14 countries, most of them representing only six countries. Therefore, a major gap in current knowledge is the lack of data from other regions in the world, particularly from developing countries. According to studies conducted in developing countries, *C. hominis* is responsible for 70--90% of human infections (reviewed in [@bib408]). Therefore, some authors suggest that the zoonotic cryptosporidiosis is less common in developing countries. However, this might not be entirely true, because there is insufficient information on *Cryptosporidium* and *Giardia* in bovids or other animal hosts in those countries. In some instances, *C. hominis* has been inferred to infect cattle in countries including India, Korea and Scotland ([@bib355]), and it is possible that *C. hominis* might infect animals other than humans in geographical regions in which no molecular investigations have been conducted. Furthermore, the molecular epidemiology of cryptosporidiosis and giardiasis in cattle in developed countries might be different from developing countries, because cattle farms in developed countries are managed intensively, whereas most of the farms in developing countries are extensive or semi-extensive. Household, small cattle farms (\<10 animals) are common in developing countries, particularly in Asia. Cattle in developing countries might have a closer contact with humans than in developed countries. Therefore, the transmission dynamics of cryptosporidiosis and giardiasis might not be the same in developed as in developing countries.

9.2. Water buffalo {#s0080}
------------------

Water buffalo (*B. bubalis*) is one of the important livestock animals in many regions of the developing world. The world\'s water buffalo population was estimated as 195 million in 2011, being mostly distributed in Asia, some Mediterranean regions and Latin American countries ([@bib313]). They contribute significantly to the agricultural economy in many parts of Asia through milk, meat, leather and draught power ([@bib390]). There are two broad lineages of water buffaloes, namely the river and swamp types. The river type is found mainly in Italy and the Indian subcontinent, whereas the swamp type is distributed from Assam in India through Southeast Asia to China ([@bib188]). Based on an early report ([@bib162]), the karyotypes (2n) of riverine (50) and swamp (48) buffaloes differ, suggesting that they are distinct species.

Although *Cryptosporidium* has been detected in the faeces of water buffaloes in a number of studies ([Table 4](#t0025){ref-type="table"} ), reports of *Giardia* in this host species are very limited. Specifically, *Cryptosporidium* and *Giardia* have been detected in the faeces from water buffaloes from Egypt ([@bib87], [@bib347]), India ([@bib39], [@bib219]), Italy ([@bib56], [@bib308], [@bib309]), Nepal ([@bib110]), Pakistan ([@bib247]), the Philippines ([@bib391]) and Spain ([@bib137]), but most of these studies have been based on the use of microscopy and coproantigen detection techniques. Although some studies have reported '*C. parvum*' in water buffalo ([@bib247], [@bib308], [@bib309]), these reports should be interpreted with some caution, as immunological methods do not allow specific diagnosis. In some studies, molecular techniques were used for the specific or genotypic identification of *Cryptosporidium* or *Giardia* (e.g. [@bib20], [@bib56], [@bib110], [@bib137], [@bib388]). For the first time, [@bib137] conducted a molecular analysis of *Cryptosporidium* in water buffaloes in Spain. Subsequently, [@bib56] detected and genetically characterised *C. parvum* and *G. duodenalis* assemblages A and E from water buffaloes from Central Italy. Here, the small subunit of ribosomal RNA gene (*SSU*) and the β-giardin (*bg*) gene were used for the amplification of *Cryptosporidium* and *Giardia* DNA, respectively. Although the significance of water buffaloes as reservoirs of cryptosporidiosis and giardiasis is limited, findings from various studies ([@bib20], [@bib56], [@bib219]) do suggest that water buffaloes might contribute to the zoonotic transmission of species or genotypes of *Cryptosporidium* and *Giardia*. Oocysts and cysts in the faeces from buffaloes can enter into food and water sources through a number of pathways. Buffaloes usually wallow in rivers, streams and other water sources. Buffalo dung is used as a fertilizer for crops. In some countries, dung is also used to line the floors and walls of houses, which represents a potential risk of transmission to humans. By these and other means, zoonotic genotypes of *Cryptosporidium* and *Giardia* in buffaloes might directly or indirectly infect humans in these developing countries. The extent to which water buffaloes contribute to the zoonotic transmission of these protists is largely unknown ([@bib313]), emphasizing the need for further investigations of riverine and swamp buffaloes in developing and developed countries.Table 4Summary of information (country, clinical symptoms, age, diagnostic techniques, % of positive samples, species/genotypes and references) relating to *Cryptosporidium* infections/cryptosporidiosis in water buffaloesCountrySymptomsHost ageDiagnostic techniques used% of test positive (no. test positive/total no.)Species/genotype detectedReferencesAustraliaNot assessed≤6, 6--24, or \>24 monthsMolecular analysis (SSU-rRNA)13% (62/476)*Cryptosporidium parvum*, *Cryptosporidium bovis*, Genotypes 1--3[@bib6]EgyptDiarrhoeic and non-diarrhoeic\<3 monthsModified Ziehl--Neelsen (MZN)14% (65/458)Not detected[@bib87]EgyptDiarrhoeic and non-diarrhoeicNot statedMZN22% (16/71)Not detected[@bib347]EgyptNot stated1 week to 4 months and adultsMolecular analysis (SSU-rRNA, *gp60*)Calves 10% (17/179), adults: 0*C. parvum* (IIdA20G1 and IIaA15G1R1), *Cryptosporidium ryanae*[@bib20]EgyptDiarrhoeic adults, not stated for calvesCalves and adultsAntibody-based coproantigen test and molecular analysis (SSU-rRNA and *gp60*)1 day to 3 months: 40% (34/85), 3 months to 1 year: 11% (6/56%), \>1 year: 4% (3/70)*C. parvum*, *C. bovis*, *C. ryanae*[@bib151]IndiaDiarrhoeic and non-diarrhoeic\<3 monthsMZN and molecular analysis (SSU-rRNA)24% (64/264)*C. parvum*[@bib219]IndiaDiarrhoeic and non-diarrhoeic\<5 monthsMZN38% (62/162)Not detected[@bib39]IndiaDiarrhoeic and non-diarrhoeicNot statedModified Ziehl--Neelsen (mZN)25% (76/305)Not detected[@bib229]ItalyAsymptomaticCalvesELISA (Enzyme-linked immunosorbent assay), IFA (Immunofluorescence assay) and molecular analysis (SSU-rRNA)14% (8/57)*C. parvum*[@bib56]ItalyNot stated2--60 daysELISA20% (35/177)Not detected[@bib308]ItalyAsymptomatic1--9 weeksELISA15% (51/347)Not detected[@bib309]NepalNot stated2--7 monthsmolecular analysis (SSU-rRNA)37% (30/81)*C. ryanae*[@bib110]PakistanDiarrhoeic and non-diarrhoeic1 day to 1 year, \>1 yearMZN24% (60/250)Not detected[@bib247]PhilippinesDiarrhoeic and non-diarrhoeic1--12 days calves and their damsKinyoun acid fast stainCalves 3% (1/38), adults 26% (10/38)Not detected[@bib391]SpainNot statedCalves, heifers and adultsIFA (Immunofluorescence antibody assay), molecular analysis (*COWP*)8% (1/12)An isolate closely relate to '*Cryptosporidium* pig-genotype'[@bib137]Sri LankaNot assessedCalves (\<6 or ≥6 months)Molecular analysis (SSU-rRNA)10% (29/297)Genotypes 9--11[@bib7]

9.3. Bovids as possible reservoirs of human cryptosporidiosis and giardiasis {#s0085}
----------------------------------------------------------------------------

There has been an increasing concern about cryptosporidiosis and giardiasis in bovids as gastrointestinal illnesses as well as infections of zoonotic significance. However, direct evidence for zoonotic transmission of cryptosporidiosis and giardiasis from animal reservoirs is limited, because of the challenges in conducting cross-transmission studies ([@bib57], [@bib408]). Nonetheless, the application of molecular techniques has provided some insights into zoonotic species and genotypes present in animals. Molecular genetic studies have shown that domestic bovids, including cattle and water buffaloes, can harbour the same *C. parvum* and *G. duodenalis* genotypes/assemblages, and thus likely constitute a public health risk as reservoirs ([@bib160]).

Although there are not many experimental studies, several small outbreaks have been reported in cattle farm workers, veterinarians and veterinary students, who had been exposed to cattle faeces ([@bib118], [@bib246], [@bib292], [@bib295], [@bib314], [@bib351]). A report also indicated that the risk of being seropositive for *Cryptosporidium* infection is higher in dairy farmers than in other people not involved in dairy farming ([@bib201]). According to the case--control studies conducted in Australia and the USA ([@bib310], [@bib324]), contact with calves has been identified as a risk factor for sporadic cryptosporidiosis in humans.

Comparatively limited information is available on zoonotic transmission of giardiasis from cattle to humans. The commonest reported *G. duodenalis* assemblage in cattle is E, which is usually not infective to humans. However, zoonotic assemblage A is increasingly being detected in cattle, indicating that this assemblage might be more widespread in cattle than previously assumed (reviewed in [@bib327]). In contrast, assemblage B has been reported from cattle only on some occasions ([@bib75], [@bib193], [@bib225], [@bib252], [@bib402]).

A long-term survey in the UK ([@bib44]) found *Cryptosporidium* in surface water draining from a livestock farm and reported the presence of oocysts throughout the year; the highest levels coincided with the calving season. In some studies, *C. parvum* and other *Cryptosporidium* species infecting cattle have been detected in different water sources in Europe ([@bib17], [@bib397]) and North America ([@bib179], [@bib325], [@bib412]), suggesting that cattle manure is a significant source of water contamination. A recent field study conducted in Spain ([@bib21]) reported *Cryptosporidium* oocysts in fresh vegetables irrigated with contaminated water, and another investigation conducted in Poland isolated *Cryptosporidium* oocysts from vegetables and fruits grown in an area of high livestock production ([@bib430]). Therefore, these studies suggest that farm animals, particularly cattle, are an important potential source of human cryptosporidiosis ([@bib158], [@bib310], [@bib324]). Although the extent of zoonotic transmission of giardiasis from bovids is not entirely clear, infected animals can pose a public health risk, because they can excrete 10^5^ to 10^6^ *Giardia* cysts per gram of faeces ([@bib371]). Therefore, future research should focus on exploring in detail the zoonotic potential and the extent of transmission of *Cryptosporidium* and *Giardia* from bovids to humans in different geographical regions of the world. This can be achieved using advanced molecular tools, which allow the characterisation of *Cryptosporidium* and *Giardia* using particular genetic markers (see [Table 5](#t0030){ref-type="table"} ).Table 5List of key genetic loci used for the genetic characterisation of *Cryptosporidium* and *Giardia*, their features and main applications[a](#t0030fna){ref-type="table-fn"}Genetic marker or coding geneDescriptionMain applicationsCryptosporidiumSmall subunit (*SSU*) of nuclear ribosomal RNASmall subunit of the ribosomeSpecific and genotypic identification70 kDa heat shock protein (*hsp70*) geneMolecular chaperonsSpecific and genotypic identificationActin geneStructural proteinSpecific and genotypic identificationβ-tubulinStructural proteinSpecific and genotypic identification*Cryptosporidium* oocyst wall protein (cowp) geneStructural proteinSpecific and genotypic identificationSecond internal transcribed spacer of nuclear ribosomal DNA (ITS-2)RibosomalSpecific identification and some subspecific characterisationThrombospondin-related attachment protein (TRAP) genesSporozoite motilitySpecific and genotypic identificationMicrosatellite locus 1 (ML1)Untranslated regionsGenotypic and subgenotypic identificationMicrosatellite locus 2 (ML2)Untranslated regionsGenotypic and subgenotypic identification60 kDa glycoprotein (*gp60*) geneEncodes surface glycoproteins GP45 and GP15Genotypic and subgenotypic identificationGiardiaGlutamate dehydrogenaseHousekeeping enzyme*G. duodenalis* assemblage and subassemblage identificationTriose phosphate isomeraseHousekeeping enzyme*G. duodenalis* assemblage and subassemblage identificationBeta-giardinStructural protein*G. duodenalis* assemblage and subassemblage identificationElongation factor 1-αInvolved in translationSpecies and *G. duodenalis* assemblage identificationFerredoxinMediates electron transferSpecies and *G. duodenalis* assemblage identificationHistone H2BNucleosomal proteinSpecies and *G. duodenalis* assemblage identificationHistone H4Nucleosomal proteinSpecies and *G. duodenalis* assemblage identificationActinStructural proteinSpecies and *G. duodenalis* assemblage identificationα-tubulinStructural proteinSpecies and *G. duodenalis* assemblage identificationChaperonin 60Heat shock proteinSpecies and *G. duodenalis* assemblage identificationOpen reading frame C4Hypothetical heat shock proteinSpecies and *G. duodenalis* assemblage identification18S rDNASmall subunit of the ribosomeSpecies and *G. duodenalis* assemblage identificationIntergenic ribosomal spacerNoncoding ribosomalSpecies and *G. duodenalis* assemblage identificationITS-1, ITS-2 and 5.8S rDNARibosomalSpecies and *G. duodenalis* assemblage identificationRibosomal protein 17aRibosomalSpecies and *G. duodenalis* assemblage identificationMlh1Function in DNA repairSpecies and *G. duodenalis* assemblage identification[^4]

9.4. The need to use effective molecular tools {#s0090}
----------------------------------------------

The accurate identification and characterisation of *Cryptosporidium* and *Giardia* are central to exploring and understanding the epidemiology of cryptosporidiosis and giardiasis, respectively. However, there are significant limitations in the detection or diagnosis of these protists using conventional microscopic, biochemical and immunological techniques, such that reliable and practical molecular methods need to be used. Using molecular methods, recognised species and genotypes of these protists can be identified and classified ([@bib70], [@bib174], [@bib185], [@bib327], [@bib330], [@bib371], [@bib374]), although the specific status of some taxa and new records need confirmation. Species and genotypes of *Cryptosporidium* and *Giardia* cannot be distinguished solely based on host origin or parasite morphology. Key microscopic and immunological methods used for the detection of *Cryptosporidium* and *Giardia*, as well as nucleic acid-based approaches for the diagnosis of cryptosporidiosis or giardiasis and the analysis of genetic variation within and among species of these protists have been reviewed elsewhere (e.g. [@bib170], [@bib185], [@bib327], [@bib409]) and are thus not covered in detail here. In previous reviews ([@bib174], [@bib185]), we discussed the advantages of particular genetic markers and PCR-coupled methods, and emphasised the benefits of using molecular tools to enhance the understanding of the epidemiology and population genetics of these protists. Of the many nucleic acid-based methods available, we have shown consistently that PCR-based single-strand conformation polymorphism (SSCP) is a practical and efficient mutation scanning technique for both diagnostic and analytical applications (cf. [@bib121]); this technique has served us well for genetic investigations of *Cryptosporidium* and *Giardia* using well-accepted genetic markers (e.g. [@bib175], [@bib173], [@bib170], [@bib186], [@bib259], [@bib256], [@bib257], [@bib258]). In the following section, this mutation scanning method, together with targeted DNA sequencing, was used to gain new insights into these protists in bovines.

10. Recent Insights into *Cryptosporidium* and *Giardia* of Bovines in Parts of Australasia and Sri Lanka {#s0095}
=========================================================================================================

Recently, we undertook some investigations of *Cryptosporidium* and *Giardia* in domestic bovines (*Bos taurus* and *B. bubalis*) in different geographical regions in New Zealand, Australia and Sri Lanka ([@bib8], [@bib5], [@bib6], [@bib7]). We genetically characterised these protists and explored their zoonotic potential. Overall, *Cryptosporidium* and *Giardia* were detected in a considerable percentage (8.3--62% for *Cryptosporidium* and 0.7--41.5% for *Giardia*, respectively) of cattle and water buffaloes in all three geographical regions studied ([@bib8], [@bib5], [@bib6], [@bib7]), providing evidence for a relatively widespread occurrence of these protists. This section discusses salient findings and proposes avenues for future research.

In New Zealand, using a PCR-based approach, we explored whether dairy calves in the Canterbury region of the South Island of New Zealand harboured genotypes of *Cryptosporidium* and *Giardia* known to infect humans ([@bib8]). The results revealed the presence of potentially zoonotic species/genotypes of these parasites. An important finding was evidence of *C. hominis* in faecal samples collected from pre- and post-weaned calves (n = 12 of 180). *Cryptosporidium hominis* found represented subgenotype IbA10G2R2, the most widely distributed subgenotype of *Cryptosporidium* infecting humans globally ([@bib171]). Although evidence of patent infection was not available, this result raises questions as to possible routes of transmission of *C. hominis* between human and cattle populations. It is not clear how these calves might have come into contact with *C. hominis*, although the dispersal of wastewater effluent on farms, which is common practice in New Zealand, is one possible source. Naturally acquired *C. hominis* infection has been reported in animals including cattle, goats, marsupials and dugongs ([@bib109], [@bib238], [@bib280], [@bib329], [@bib355]). The findings of our study ([@bib8]) might suggest a need for future investigations of the host specificity of *C. hominis*, and to understand its transmission between human and cattle populations. Noting this, *C. parvum* (subgenotypes IIaA15G3R1, IIaA19G3R1 and IIaA23G4) was the commonest species detected, reinforcing the potential of cattle as zoonotic reservoirs for this species. According to a report on foodborne diseases in New Zealand ([@bib271]), the highest rates of cryptosporidiosis notifications in humans have been recorded in the Canterbury region. Furthermore, contact with farm animals has been reported as the main risk factor for human cryptosporidiosis in New Zealand ([@bib271]). It should be remarked, however, that the molecular methods chosen for this study (based on the detection and characterisation of the *gp60* gene) did not use primers able to detect other common species and genotypes of *Cryptosporidium* known to commonly infect cattle (e.g. *C. andersoni*, *C. bovis* and *C. ryanae*; see [@bib109], [@bib301], [@bib406]). We also examined dairy cattle in Canterbury for the presence of *Giardia* ([@bib8]). Both *G. duodenalis* assemblage A and E were detected in faecal samples from these animals. Surprisingly, this is the first report of assemblage E in New Zealand, although it is the most commonly reported assemblage of *G. duodenalis* in cattle globally. This may be explained by the fact that only a small number of molecular studies have been conducted in this country ([@bib157], [@bib198], [@bib402]), rather than a limited presence of this assemblage. Together, these findings suggest considerable potential for zoonotic transmission in the Canterbury region, and indicate that additional studies of the zoonotic potential of cattle in other regions of New Zealand are warranted.

In Australia, a molecular epidemiological survey of *Cryptosporidium* and *Giardia* was conducted for dairy and beef calves from five farms in an open drinking water catchment area in Victoria ([@bib5]). The results of this study showed that a considerable proportion of cattle, particularly dairy calves, harboured *C. parvum* and *G. duodenalis* assemblage A. These results are in agreement with previous investigations from other parts of Australasia ([@bib31], [@bib251], [@bib252], [@bib259], [@bib402]). In addition to than *C. parvum*, *C. bovis*, *C. ryanae* and a new genotype of *Cryptosporidium* were detected. Based on the analysis of *gp60* gene sequences, all of the *C. parvum* isolates from Victorian cattle ([@bib5]) were identified as genotype IIa and subgenotype A18G3R1. Previous studies conducted in Australia have reported that *C. parvum* IIaA18G3R1 was a common subgenotype in humans ([@bib176], [@bib173], [@bib394]) and cattle ([@bib252]). Therefore, published reports ([@bib5], [@bib251], [@bib252], [@bib259]) indicate potential transmission of *C. parvum* between cattle and human populations in Australia. Intriguingly, although *C. parvum* IIaA18G3R1 has been reported with high prevalence in Australia, it is rarely reported elsewhere in the world ([@bib171]). Why this genotype should be so common in Australia and not elsewhere is not clear, but may indicate a predilection for Australian cattle.

Another interesting finding was that most of the *C. parvum* cases found (82.9% of 35 infections) were linked to a particular dairy farm (two sampling time-points) ([@bib5]). This result could be associated with differences in management practices, because calves on this farm were reared at a relatively high stocking density in pens with sawdust bedding, whereas calves on all other farms were kept on paddocks with less crowding. Previous epidemiological studies have reported that there is a link between management practices and the occurrence of *C. parvum* in calves ([@bib26], [@bib120], [@bib217], [@bib378]). A number of potential risk factors were identified in these studies, including large herd size, use of multi-cow maternity facilities, cleanliness of calf pens and a long calving season. The stocking density of calves, particularly prior to weaning, and their housing in pens rather than on paddocks are known risk factors for *Cryptosporidium* transmission ([@bib62], [@bib228]). Noting this, adequate consumption of colostrum by neonatal calves is a protective factor against *Cryptosporidium* and other pathogens causing diarrhoea (e.g. Coronavirus, Rotavirus and *Escherichia coli*) ([@bib34], [@bib84]) and may also have contributed to these differences.

*Giardia duodenalis* assemblage E was the most frequently identified assemblage in both dairy and beef cattle in Victoria ([@bib5]), which is consistent with the earlier studies conducted in other states of Australia ([@bib31], [@bib252], [@bib267]) and in other countries ([@bib23], [@bib195], [@bib380]). In contrast, *G. duodenalis* assemblage A was the most frequently isolated from Victorian water buffaloes ([@bib6]). This finding is consistent with reports from water buffaloes from Italy ([@bib56]). Although these data suggest potential for these animals to act as zoonotic sources of giardiasis, the limited molecular data for water buffalo elsewhere strongly suggest that these findings are preliminary, and more investigation is needed. Similarly, studies of *Cryptosporidium* infection in water buffaloes are also limited, with only a small number utilizing molecular tools ([@bib20], [@bib110], [@bib137], [@bib219], [@bib388]). These studies have reported a unique *Cryptosporidium* genotype, which is closely related to *C. ryanae*, in most of the samples from buffaloes. Recent findings show that the genotypes of *Cryptosporidium* found in water buffaloes are clearly different from those found in cattle ([@bib6]). Of the two genotypes (1 and 2) identified in Victorian water buffaloes ([@bib6]), genotype 1 was identical to those previously reported for isolates from water buffaloes ([@bib20], [@bib110], [@bib388]), whereas genotype 2 had not been reported previously. Therefore, further investigations are required to understand taxonomic status, host specificity and virulence of these genotypes found in water buffaloes.

Although zoonotic species/genotypes of *Cryptosporidium* and *Giardia* were detected in a considerable proportion of samples collected from Australia and New Zealand ([@bib8], [@bib5], [@bib6]), this was not the case in bovines in Sri Lanka, where the zoonotic risk of these protists appeared to be minimal in the regions studied ([@bib7]). Whilst previous studies in Sri Lanka have established the occurrence of cryptosporidiosis and giardiasis in humans ([@bib285], [@bib286], [@bib287]) and animals ([@bib27], [@bib86], [@bib261], [@bib260]), ours is the first study documenting species and genotypes of *Cryptosporidium* and *Giardia* in domestic bovids in this country using molecular tools (cf. [@bib174], [@bib185]). Interestingly, eight new genotypes of *Cryptosporidium* were identified. The absence of *C. parvum* from any of the samples collected from 1- to 3-month-old calves was unexpected, because it is the most commonly reported species of *Cryptosporidium* in preweaned calves throughout the world ([@bib168], [@bib406], [@bib407]). The identification of many new genotypes and the unexpected absence of *C. parvum* suggest that the molecular epidemiology of cryptosporidiosis in Sri Lanka might be distinct from Australasia and other regions in the world. This particular hypothesis needs further testing. As in other countries, *G. duodenalis* assemblage E was more common than assemblage A in dairy calves, whereas only livestock-specific assemblage E was detected in water buffaloes. These findings all suggest that zoonotic transmission of giardiasis from cattle and water buffaloes in our study regions in Sri Lanka was limited at the time of investigation. However, this proposal needs testing in the future. In addition, it would be useful to conduct studies of *Cryptosporidium* and *Giardia* in other neighbouring countries in South Asia.

The identification of zoonotic species and genotypes of *Cryptosporidium* and *Giardia* in some water buffalo populations ([@bib6], [@bib20], [@bib56], [@bib151], [@bib219]) indicates their public health significance. Like cattle, water buffaloes pass substantial amounts of faeces, which may contain large numbers of oocysts/cysts when they are infected with *Cryptosporidium* and/or *Giardia*. Although these parasites have been reported in water buffaloes in a number of studies ([@bib39], [@bib87], [@bib247], [@bib308], [@bib309]), most investigations did not employ molecular tools. Advanced PCR-based techniques have been developed and applied extensively to the genetic characterisation of *Cryptosporidium* and *Giardia* of cattle, but not water buffaloes. Furthermore, there are very few publications reporting *Cryptosporidium* and *Giardia* in water buffaloes from Asian countries which have the largest proportion of the world\'s water buffalo population (\>90%). Buffaloes usually wallow in water sources, which likely make them a major source of water contamination through faecal contamination during wallowing. Given these knowledge gaps, there is major scope for future studies of the molecular epidemiology of cryptosporidiosis and giardiasis in water buffaloes and other bovids.

Currently, it is widely accepted that there is an age-related distribution of *Cryptosporidium* species and genotypes in cattle. Several studies conducted in Denmark, Germany, Ireland, the UK and the USA have shown that *C. parvum* is more common in neonates and very young calves. In contrast, *C. bovis* and *C. ryanae* predominate in older calves, and *C. andersoni* is more prevalent in adults ([@bib46], [@bib99], [@bib107], [@bib109], [@bib217], [@bib341], [@bib364], [@bib369]). One of our recent studies ([@bib5]) showed a similar pattern in Victorian dairy and beef cattle, in which *C. parvum* was detected exclusively in \<3-month-old and *C. bovis* was detected mostly in \>3-month-old calves. However, such a pattern was not evident in New Zealand ([@bib8]) likely due to the relatively small sample size in the study. In contrast, *C. parvum* was not detected in faecal samples collected from dairy calves in Sri Lanka ([@bib7]), rather a new genotype with 99% homology to *C. bovis* was the commonest. Interestingly, other studies conducted in China, India, Georgia, Nigeria and Sweden have also reported a similar situation, where *C. bovis* has been the predominant species in 1--60-day-old calves, instead of *C. parvum* (see [@bib109], [@bib422], [@bib423], [@bib396], [@bib424]). Therefore, evidence provided in this review suggests that the age-related distribution of *Cryptosporidium* species in cattle is not the same for all countries or geographical regions.

For *Giardia*, assemblages A and E were isolated from both cattle and water buffaloes, although there were differences in proportions of test-positive samples in different geographical regions studied ([@bib8], [@bib5], [@bib6], [@bib7]). Overall, *G. duodenalis* assemblage E was most frequent in cattle sampled from all geographical regions studied. This finding was consistent with previous studies ([@bib23], [@bib37], [@bib195], [@bib252], [@bib380]). *G. duodenalis* assemblage A was also detected in cattle in the geographical regions studied ([@bib8], [@bib5], [@bib7]), but with fewer occurrences than assemblage E. These two assemblages were also identified in water buffaloes ([@bib6], [@bib7]). However, *G. duodenalis* was detected only on some farms in Australia and Sri Lanka ([@bib6], [@bib7]). Interestingly, one of the two water buffalo farms in Victoria, Australia, had a higher occurrence of *G. duodenalis* assemblage A than assemblage E at two samplings (6 months apart) ([@bib6]). In contrast, all the samples collected from the other farm in Victoria were test-negative for *Giardia* ([@bib6]) on both occasions. In Sri Lanka, only two of 297 water buffaloes had *G. duodenalis* assemblage E ([@bib7]). The limited presence of assemblage A compared with assemblage E suggested that the public health risk of giardiasis in bovines does not appear to be as great as previously thought.

Another interesting finding was that samples collected from selected dairy farms had a higher occurrence of *Cryptosporidium* and *Giardia* than those from beef farms in the same geographical region in Victoria ([@bib5]). Prior to this report, only few studies have compared occurrence and zoonotic potential of *Cryptosporidium* and *Giardia* in dairy and beef cattle in the same region ([@bib81], [@bib133], [@bib386]). Consistent with the previous findings ([@bib81], [@bib190], [@bib266]), both *C. parvum* and *G. duodenalis* assemblage A were detected in higher proportions of dairy than beef herds. Factors that might contribute to differences between dairy and beef calves could relate to variations in environmental and/or host factors. A high prevalence of *C. parvum* in neonates is likely linked to the immature immune status of young animals ([@bib99]). Therefore, the transfer of passive immunity is likely a major host factor preventing infection at a young age ([@bib84], [@bib136], [@bib264]). Beef calves usually have immediate and ready access to colostrum, because they are usually kept with their dam for a longer time than dairy calves are. In addition, it has been shown that beef cows produce a significantly higher concentration of immunoglobulin in their colostrum than dairy cows ([@bib143]). In addition, overcrowding (high population density) in dairy calf production systems is an important environmental factor, which can increase infection rates of *Cryptosporidium* and *Giardia* in dairy calves ([@bib221]). Overcrowding causes stress that reduces immunity in animals ([@bib297], [@bib375]). Therefore, proper animal management is a key requirement for the control of cryptosporidiosis, giardiasis and other infectious diseases in cattle herds.

11. Concluding Remarks {#s0100}
======================

Recent studies ([@bib8], [@bib5], [@bib6], [@bib7]) have contributed to knowledge of the genetic diversity and public health significance of *Cryptosporidium* and *Giardia* from domestic bovids (*B. taurus* and *B. bubalis*) in selected geographical areas of Australasia and Sri Lanka. The findings from these studies highlight the need for expanded research into the epidemiology of *Cryptosporidium* and *Giardia*.

The detection of zoonotic species/genotypes of *Cryptosporidium* and/or *Giardia* from domestic bovids (*B. taurus* and *B. bubalis*) reinforces the importance of studying their prevalence and transmission dynamics in different regions of the world. Although *Cryptosporidium* and *Giardia* have been detected in bovids in many studies, their fate and transport in the environment and water are not well documented or understood. Therefore, future research might focus on investigating the fate of oocysts or cysts of *Cryptosporidium* and *Giardia* released by bovids and other animals into the environment. In addition, methods that can determine oocyst and cyst viability and infectivity should be developed. Advanced molecular tools (cf. [@bib171], [@bib185]; [@bib330], [@bib408]) could be used for the detailed genetic characterisation of *Cryptosporidium* and *Giardia* in clinical and environmental samples. Studies might also focus on cryptosporidiosis and giardiasis in various livestock and wild animals, to assess their significance as reservoirs for transmission to humans. There is also a need to expand future research to less privileged countries, where cryptosporidiosis and giardiasis are particularly prevalent in human populations. Many people in rural communities in Asian countries keep cattle, water buffaloes and/or other livestock animals as a source of income. However, very little is known about the zoonotic transmission in such countries. Therefore, molecular studies might focus on understanding the epidemiology of zoonotic infections in regions where animals live in close proximity to humans. In the future, we expect to see a substantial expansion in the use of genome-wide sequencing (e.g. [@bib169], [@bib172], [@bib167]) for the characterisation of *Cryptosporidium* and *Giardia* isolates as well as the definition of a broad range of genetic markers for use in diagnostic and analytical tools. Such tools could offer unique opportunities to address questions regarding the complex network of epidemiological and biological factors involved in the interactions among these protists, their hosts and the environment. The integrated use of advanced genomic and bioinformatic tools will also be crucial to underpin studies of the systems biology of these protists on an unprecedented scale, and might also provide prospects for the development of new interventions.
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[^1]: See [@bib319].

[^2]: See [@bib332].

[^3]: No molecular data available for this 'species'.

[^4]: Information taken from key review articles (including [@bib409], [@bib174], [@bib257], [@bib327], [@bib185]).
